Quality Control Material for Qualitative Determination of Antibodies to Hepatitis B Core Antigen (Anti-HBc) by Chemiluminescent Immunoassay on CL Series Analyzers

We present a control material used for qualitative quality control in the determination of antibodies to the hepatitis B core antigen (Anti-HBc) using chemiluminescent immunoassay on CL series analyzers. The following options are available:

Option 1

Anti-HBc Negative Control in clinical samples, volume: 3 × 2.0 ml per vial. Includes:

Anti-HBc Negative Control, 2.0 ml – 3 vials
Value table for the control material series
Instructions for use

Option 2

Anti-HBc Negative Control in clinical samples, volume: 6 × 2.0 ml per vial. Includes:

Anti-HBc Negative Control, 2.0 ml – 6 vials
Value table for the control material series
Instructions for use

Option 3

Anti-HBc Positive Control in clinical samples, volume: 3 × 2.0 ml per vial. Includes:

Anti-HBc Positive Control, 2.0 ml – 3 vials
Value table for the control material series
Instructions for use

Option 4

Anti-HBc Positive Control in clinical samples, volume: 6 × 2.0 ml per vial. Includes:

Anti-HBc Positive Control, 2.0 ml – 6 vials
Value table for the control material series
Instructions for use

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Quality Control Material for Qualitative Determination of Antibodies to Hepatitis B Core Antigen (Anti-HBc) by Chemiluminescent Immunoassay on CL Series Analyzers, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.

Back